• Ownership

Steven M. Paul - Insider Trading & Ownership

Entity
Individual
Location
C/O Eli Litty & Co, LIIy Corporate Center Dc 1093, Indianapolis, IN
Summary
The estimated net worth of Steven M. Paul is at least $4.95M dollars as of June 6, 2024. Steven M. Paul is the Director of Rapport Therapeutics, Inc. and owns shares of Rapport Therapeutics, Inc. (RAPP) stock worth about $4.77M. Steven M. Paul is the Director of ALNYLAM PHARMACEUTICALS, INC. and owns shares of ALNYLAM PHARMACEUTICALS, INC. (ALNY) stock worth about $185K.
All Insider Reports
All Insider Reports

Ownership of Steven M. Paul

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
RAPP Rapport Therapeutics, Inc. Director $4.77M Jun 6, 2024
ALNY ALNYLAM PHARMACEUTICALS, INC. Director $185K Apr 1, 2022
KRTX Karuna Therapeutics, Inc. Director $0 Mar 18, 2024
SAGE Sage Therapeutics, Inc. Director Jan 3, 2024
VYGR Voyager Therapeutics, Inc. Director Jun 3, 2021

Insider Transactions Reported by Steven M. Paul:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.